MiR-22-3p Suppresses Cell Migration and Invasion by Targeting PLAGL2 in Breast Cancer

Area of Science:

• Oncology
• Molecular Biology
• Gene Expression

Background:

• Breast cancer is a leading cause of mortality in women worldwide.
• Understanding the molecular mechanisms underlying breast cancer progression is crucial for developing effective therapies.
• MicroRNAs (miRNAs) play significant roles in cancer development and progression.

Purpose of the Study:

• To investigate the expression of miR-22-3p in breast cancer tissues.
• To elucidate the mechanism by which miR-22-3p targets PLAGL2 to inhibit breast cancer cell invasion and migration.
• To evaluate the potential of miR-22-3p as a therapeutic target for breast cancer.

Main Methods:

• Real-time fluorescence quantitative reverse transcriptase PCR (qRT-PCR) was used to measure miR-22-3p expression in 41 paired breast cancer and para-cancer tissues.
• Cell proliferation was assessed using the growth curve method after miR-22-3p over-expression in MCF-7 cells.
• TargetScan software predicted target genes, and luciferase reporter gene assays validated the binding of miR-22-3p to PLAGL2 mRNA.

Main Results:

• MiR-22-3p expression was significantly decreased in breast cancer tissues compared to normal tissues (p<0.05).
• Over-expression of miR-22-3p inhibited MCF-7 cell proliferation.
• Pleomorphic adenoma gene-like protein 2 (PLAGL2) was identified as a direct target of miR-22-3p, with a negative correlation between their expression levels in MCF-7 cells.

Conclusions:

• MiR-22-3p suppresses breast cancer cell proliferation by targeting PLAGL2.
• MiR-22-3p holds potential as a therapeutic strategy for breast cancer treatment.
• Targeting the miR-22-3p/PLAGL2 axis may offer a novel approach for breast cancer therapy.